FDA approval of exenatide, its first generic injectable GLP-1 agonist, Amneal (2024) Teva announces FDA approval and launch of generic Saxenda (liraglutide injection) first generic GLP-1 indicated for weight loss, Teva Pharmaceuticals (2025) Exenatide, DailyMed (2025) Byetta, DailyMed (2025) Liraglutide (generic Victoza), DailyMed (2025) Liraglutide (generic Saxenda), DailyMed (2025) Victoza, DailyMed (2025) Saxenda, DailyMed (2025) Compounding and the FDA: Questions and answers, U.S
While minor effects like temporary bruising, swelling, and numbness are common, they typically resolve quickly without intervention
The data are now available and in the references
Get the results in the Concerns and Cautions section of the Protein Powders Review -- which also discusses a concern with dehydration
While broccoli sprouts are the first stages of the broccoli plant, theyre not nutritionally identical to the mature vegetable